About
Dr. Scott Gottlieb was appointed a UnitedHealth Group director in November 2025 and serves on the Health and Clinical Practice Policies and Public Responsibility Committees. He served as the 23rd Commissioner of the U.S. Food and Drug Administration from 2017 to 2019 and is a Senior Fellow at the American Enterprise Institute and a Special Partner at New Enterprise Associates, and also serves as a director of Pfizer, Tempus AI and Illumina.
Roles
Unitedhealth Group Inc.
Independent Director · Current role
2025–present
American Enterprise Institute
Senior Fellow
2019–Present
New Enterprise Associates
Special Partner
2019–Present
U.S. Food and Drug Administration
Commissioner
2017–2019
U.S. Food and Drug Administration
Deputy Commissioner for Medical and Scientific Affairs
2005–2007
U.S. Food and Drug Administration
Director of Medical Policy Development
2004
U.S. Food and Drug Administration
Senior Advisor to the Commissioner for Medical Technology
2003–2004
Director Compensation
FY 2025
Fees earned or paid in cash
$0
Also at Unitedhealth Group Inc.